TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
4.980
-0.110 (-2.16%)
At close: Jun 9, 2026, 4:00 PM EDT
5.09
+0.11 (2.22%)
After-hours: Jun 9, 2026, 6:33 PM EDT
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $4.73 million as of June 9, 2026. Its market cap has decreased by -19.01% in one year.
Market Cap
4.73M
Enterprise Value
-7.90M
1-Year Change
-19.01%
Ranking
Category
Stock Price
$4.98
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $4.73M, a decrease of -90.11%. That is a compound annual growth rate of -37.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 4.84M | -22.77% |
| Dec 31, 2025 | 6.26M | 166.92% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
| Jul 9, 2021 | 47.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cardio Diagnostics Holdings | 5.80M |
| Aptevo Therapeutics | 5.58M |
| FibroBiologics | 5.56M |
| Alaunos Therapeutics | 5.52M |
| BioAtla | 5.52M |
| XTL Biopharmaceuticals | 5.47M |
| CollPlant Biotechnologies | 5.35M |
| Mustang Bio | 5.08M |